Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more. By Rebecca Robbins and Carolyn Y. Johnson The Food and Drug Administration’s approval on Wednesday of a ...

The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of ...

The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The Food and Drug Administration (FDA) on Wednesday approved Rasonque, ...

The US Food and Drug Administration has approved a treatment for pancreatic cancer that nearly doubled the overall survival time for patients in clinical trials. The drug, daraxonrasib, sold under the ...

A newly approved pill nearly doubled median survival by blocking a cancer-driving protein once considered “undruggable.” Daraxonrasib, sold as Rasonque, is the first FDA-approved oral RAS inhibitor ...

Revolution Medicines Inc. won US approval for a breakthrough pill that lengthens the lives of patients with advanced pancreatic cancer, a major advance against one of the hardest-to-treat tumor types.

For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within ...

For four decades, cancer researchers fought to disable a stubborn mutation that made pancreatic cancer a death sentence—to little avail. Now, doctors have a medicine that targets the mutation. The ...

The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms of cancer.

The Food and Drug Administration on Wednesday approved a groundbreaking pancreatic cancer drug that experts predict will transform treatment for the notoriously deadly disease. The drug, Revolution ...

FDA officials approve first-of-a-kind pill called daraxonrasib to fight one of the deadliest types of cancer The US Food and Drug Administration (FDA) approved a groundbreaking new drug for the most ...